Kellerhals Carrard with Stille on the acquisition of all the shares of S&T

Kellerhals Carrard has acted as legal counsel to Stille, a medical device company, in acquiring all shares in Switzerland-based S&T, a manufacturer of microsurgical instruments, in exchange for CHF 6 million paid in cash upon completion of the transaction and financed through Stille’s existing cash liquidity and bank loans. In addition to, CHF 2.5 million paid in Stille shares and a possible further contingent consideration of maximum CHF 3 million on 8 July 2021. Also part of the deal, is the Germany-based sister Company S&T, whose primary function has been to facilitate the export of products from S&T to the EU, for a purchase price of EUR 25,000. S&T will become a part of Stille’s business area Surgical Instruments.

Markus Spingler, CEO at S&T, will become the new business unit manager at Stille, with global responsibility for the business area. Markus will also be part of Stille’s management team.

Kellerhals Carrard advised Stille in this transaction with a team led by partner Emanuel Dettwiler (corporate/m&a, pictured) and comprised senior associates Sophie Holdt (corporate/m&a), Melanie Huber (employment), Laura Manz (insurance) and Marco Sibold (taxes) as well as associates Jon Oetiker and Larissa Simeon (both corporate/m&a).